Key result
Point-of-care testing for quick cortisol assay demonstrated 99.1% sensitivity and 81.6% specificity for determining adrenal vein sampling success compared to routine methods.
Why the study?
The study was conducted to assess the clinical performance of point-of-care testing for quick cortisol assay during adrenal vein sampling using a portable quantitative assay instrument.
Does point-of-care testing for quick cortisol assay accurately determine adrenal vein sampling success compared to routine cortisol measurement in patients with primary aldosteronism?
Observational (n=48)
Yes
Does point-of-care testing for quick cortisol assay accurately determine adrenal vein sampling success compared to routine cortisol measurement in patients with primary aldosteronism?
A novel portable point-of-care testing device for quick cortisol assay provides rapid and highly sensitive confirmation of adrenal vein sampling success, facilitating intraprocedural decision-making for primary aldosteronism.
This study assessed the clinical performance of point-of-care testing (POCT) for quick cortisol assay (QCA) during adrenal vein sampling (AVS) using a newly invented portable quantitative assay instrument. An observational study was conducted prospectively at two centres in Japan. Forty-eight patients with primary aldosteronism considered for adrenalectomy were enrolled in this study and underwent AVS. Three basal adrenal vein samples from each adrenal vein and two from the inferior vena cava were collected sequentially. The cortisol concentration of adrenal vein samples was measured by routine method and QCA. A total of 338 adrenal vein samples were analysed from 250 sites to determine AVS success or failure. The distribution of turnaround time of the QCA for AVS success or failure followed a normal distribution with an average of 20.5 min. A positive correlation between the routine method and QCA was observed regarding cortisol concentration or selectivity index. No significant difference between the two methods was observed regarding the success rate of AVS. Using the routine method as a reference, the sensitivity and specificity of AVS success or failure were 99.1% (210/212) and 81.6% (31/38), respectively. Easy, quick, portable, and precise POCT-QCA demonstrated its compatibility with routine methods regarding clinical performance.
No takes yet. Share an insight, caveat, or question.
Aiga et al. (2023) conducted an observational in Primary aldosteronism (n=48). Point-of-care testing for quick cortisol assay (QCA) vs. Routine cortisol measurement was evaluated on Sensitivity of adrenal vein sampling (AVS) success or failure (95% CI 96.6-99.9). Point-of-care testing for quick cortisol assay demonstrated 99.1% sensitivity and 81.6% specificity for determining adrenal vein sampling success compared to routine methods.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: